Literature DB >> 1740672

Pathology of HIV-1 infection of the central nervous system. A review.

L R Sharer1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1740672     DOI： 10.1097/00005072-199201000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN： 0022-3069            Impact factor:   3.685


× No keyword cloud information.
  53 in total

Review 1.  Biomarkers for neuroAIDS: the widening scope of metabolomics.

Authors:  Gurudutt Pendyala; Elizabeth J Want; William Webb; Gary Siuzdak; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-10-10       Impact factor: 4.147

2.  Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease.

Authors:  T E Lane; M J Buchmeier; D D Watry; H S Fox
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

3.  Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia.

Authors:  J T Shieh; A V Albright; M Sharron; S Gartner; J Strizki; R W Doms; F González-Scarano
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

Authors:  M J Harrison; S P Newman; M A Hall-Craggs; C J Fowler; R Miller; B E Kendall; M Paley; I Wilkinson; B Sweeney; S Lunn; S Carter; I Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

5.  HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.

Authors:  Beau M Ances; David B Clifford
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

Review 6.  Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).

Authors:  P Portegies
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro.

Authors:  Fatiha Radja; Denis G Kay; Steffen Albrecht; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques.

Authors:  Carole Harbison; Ke Zhuang; Agegnehu Gettie; James Blanchard; Heather Knight; Peter Didier; Cecilia Cheng-Mayer; Susan Westmoreland
Journal:  J Neurovirol       Date:  2014-01-25       Impact factor: 2.643

9.  Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.

Authors:  H A Gelbard; H S Nottet; S Swindells; M Jett; K A Dzenko; P Genis; R White; L Wang; Y B Choi; D Zhang
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Brain Res       Date:  2008-07-17       Impact factor: 3.252
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.